Could Teriparatide Replace Percutaneous Vertebral Augmentation for Patients with Osteoporotic Vertebral Compression Fracture to Some Extent? [Letter]

Jiaming Zhou, Yuan Xue Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Yuan XueDepartment of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaTel...

Full description

Bibliographic Details
Main Authors: Zhou J, Xue Y
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/could-teriparatide-replace-percutaneous-vertebral-augmentation-for-pat-peer-reviewed-article-CIA
Description
Summary:Jiaming Zhou, Yuan Xue Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Yuan XueDepartment of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaTel +86 22 60814688Fax +86 22 27219052Email xueyuanzyy@163.com We read with great interest the article by Kong et al.1 In their study, the authors found that for patients with osteoporotic vertebral compression fracture (OVCF), treatment with percutaneous kyphoplasty (PKP) and teriparatide showed a lower risk of new vertebral compression fracture (NVCF) and better clinical outcomes than with PKP and basic treatment (calcium and vitamin D). We wish to express our opinion on this topic. View the original paper by Kong and colleagues  
ISSN:1178-1998